VERNON B. WILLIAMS, M.D.
6801 Park Terrace. Los Angeles, CA 90045
EDUCATION University of Michigan, Ann Arbor, MI Inteflex Accelerated Pre-Medical/Medical Program
POST-GRADUATE TRAINING 1996 - 1997 Johns Hopkins Hospital, Baltimore, MD Department of Anesthesiology and Critical Care 1993 - 1996 University of Maryland Medical Center, Baltimore, MD
1992 - 1993 Intern Henry Ford Hospital, Detroit, MI
EMPLOYMENT HISTORY 2007- Present Sports Concussion Institute, Los Angeles, CA 1997 - Present Director, Sports Neurology and Pain Management Kerlan-Jobe Orthopaedic Clinic, Los Angeles, CA 2005 – 2006 Director of Sports Neurology and Pain ManagementSports Concussion Institute, Marina Del Rey, CA 1999 – 2005 Medical Director-HealthSouth Physical TherapyIntegrated Medical Plaza, Los Angeles, CA 1994 – 1998 Innovative Medical Research, Incorporated, Towson, MD
1995 - 1996 Director of Medical Student Core Neurology CurriculumUniversity of Maryland Medical Center, Baltimore, MD
1994 - 1996 Ethical Advisory Committee MemberUniversity of Maryland Medical Center, Baltimore, MD Student Fellow of the American Heart AssociationHenry Ford Hospital/Wayne County Medical Examiner’s Office Detroit, MI University of Michigan Medical Center, Ann Arbor, MI Department of Physical Medicine and Rehabilitation 1984 - 1986 Henry Ford Hospital, Detroit, MI
PUBLICATIONS
1. . Cocaine Associated Intracranial Hemorrhage: Absence of Vasculitis in Fourteen Cases.
1. . Williams V, Pappagallo M. Central Pain. In: Raja S (Ed.) Essentials of Pain Medicine.
1. . Williams V, Pappagallo M. Entrapment neuropathies. In: Raja S (Ed.) Essentials of Pain
Williams V, Staats P. Intrathecal Baclofen for the Management of Uncontrolled Spasticity. PAIN DIGEST, 1998;8:158-165
CLINICAL RESEARCH As Primary Investigator: Phase II, Double Blind, Placebo Controlled, Parallel, Four Week Evaluation of Efficacy and
Safety of Multiple Doses of CJ-13,974 in Subjects With Moderate to Severe Chronic Back Pain. Kerlan-Jobe Orthopedic Clinic. Los Angeles, CA; 1998
A Multicenter Double Blind, Randomized, Placebo Controlled, Parallel Group Clinical study of
the Safety, and Efficacy of Botox (Botulinum Toxin Type-A) Purified Neurotoxin Complex Injections Into Local Areas of Muscle Spasm in Subjects With Chronic Low Back Pain. Kerlan-Jobe Orthopedic Clinic. Los Angeles, CA; 1999
A Multicenter, Double-Blind, Placebo Controlled, Parallel Group, Study of Two Dose Levels of
Oral Eletriptan and Two Dose Levels of Oral Sumatriptan For The Acute Treatment of Migraine. Innovative Medical Research. Baltimore, MD; 1996.
Two-Period Crossover Comparison of Rizatriptan (5mg p.o. and 10mg p.o.) To Sumatriptan
(25mg p.o. and 50mg p.o.) Innovative Medical Research. Baltimore, MD; 1996
A Randomized, Double-Blind, Placebo-Controlled, Twelve Month Safety and Efficacy Trial of
120, 240, and 360mg TID of Idebenone (CV-2619) In Patients With Probable Alzheimer's Disease. Innovative Medical Research. Baltimore, MD; 1996
Protocol for a multicentre, long-term study to maximize migraine relief with 311C90
(MAXIMM). Innovative Medical Research. Baltimore, MD; 1996
As Sub-Investigator: A randomized, parallel, double-blind, double-dummy, placebo-controlled study to determine the
onset of action of PHZ 136 and Motrin IB in patients with acute muscle-contraction (tension) headache. Innovative Medical Research. Baltimore, MD; 1996
The efficacy and safety of alniditan (1.4 0r 1.8mg SC) vs. sumatriptan (6mg SC) in the acute
treatment of migraine: a randomized, double-blind, placebo controlled single-dose trial. Innovative Medical Research. Baltimore, MD; 1996
A randomized, double-blind, placebo-controlled, parallel group, multicenter, single-dose, dose-
range-finding study to assess the efficacy and tolerability of VML 251 in the acute treatment of migraine. Innovative Medical Research. Baltimore, MD; 1996
An open, multicenter study to evaluate the safety of a recombinant DNA-expressed protein
vaccine for Lyme disease in subjects previously enrolled in Lyme 008 and 005 studies. Innovative Medical Research. Baltimore, MD; 1996
A clinic initiated, double-blind, placebo-controlled, multicenter study to assess the safety and
efficacy of topical n-docosanol 10% cream (Lidakol) in patients with early stage episodes of acute, recurrent herpes labialis. Innovative Medical Research. Baltimore, MD; 1996
An active comparator-controlled, parallel-group, one year, double-blind study, conducted under
in-house blinding conditions, to assess the safety and efficacy of MK-0966 vs. diclofenac sodium in patients with osteoarthritis of the knee or hip. Innovative Medical Research. Baltimore, MD; 1996
A randomized, parallel, double-blind, placebo-controlled study to determine the onset of action of
Excedrin Extra Strength and Advil in episodic tension-type headache pain. Innovative Medical Research. Baltimore, MD; 1995
A single-center, double blind, randomized, parallel-group, single dose, placebo-controlled study to
evaluate safety and effectiveness of Excedrin Extra Strength in alleviating the headache pain of an acute migraine attack. Innovative Medical Research. Baltimore, MD; 1995
Evaluation of the protective efficacy, safety, and immunogenicity of a recombinant DNA-
expressed protein vaccine for Lyme disease in healthy subjects. Innovative Medical Research. Baltimore, MD; 1995
A clinic initiated longitudinal study entitled Assessing Migraine Severity II: Identifying
Migraneurs Most in Need of Care. Innovative medical Research. Baltimore, MD; 1994
INVITED LECTURE/ CONSULTANT ACTIVITIES
Daniel Freeman Marina Orthopedic Grand Rounds
HealthSouth Worker’s Compensation Symposium
Kerlan-Jobe Orthopaedic Clinic Worker's Compensation Update
Centinela Medical Center Physician’s Retreat
Grand Rounds Cedars-Sinai Department of Neurosurgery
SEIU UHW West & Joint Employer Education Fund
Community Lecture-Pain Management, Marina Del Rey
Community Lecture-Pain Management, Irvine
Community Lecture-Pain Management, Manhattan Beach
Community Lecture-Non-Surgical Spine Treatment, Torrance
American Academy of Neurology National Conference
American Academy of Neurology National Conference
Sports Concussion Institute Annual Summit on Concussion
Plenary Session Speaker and Session Lecturer 2007
Sports Concussion Institute Annual Summit on Concussion
Plenary Session Speaker and Session Lecturer 2008
Sports Concussion Institute Annual Summit on Concussion
Plenary Session Speaker and Session Lecturer 2009
Co-Chair Sports Concussion Institute Annual Summit 2009
The “Contender” Reality Boxing television series 2007-2008
PROFESSIONAL MEMBERSHIPS/ BOARD ACTIVITES
Kerlan-Jobe Orthopaedic Foundation Board of Directors Team HEAL Board of Directors Velocity Sports Performance Advisory Board Elite Sports Performance Advisory Board American Medical Association
CERTIFICATION and LICENSURE American Board of Psychiatry and Neurology Medical Board of California : License # G84209 DEA Certification for Opioid Withdrawal w/Buprenorphine
MINOXIDIL BAILLEUL 2 %, solution pour application cutanée Veuillez lire attentivement cette notice avant d'utiliser ce médicament. Elle contient des informations importantes pour votre traitement. Ce médicament est une spécialité d'AUTOMEDICATION qui peut être utilisée sans consultation ni prescription d'un médecin. La persistance des symptômes, l'aggravatio
Diabetes, Síndrome Metabólico y Enfermedad CardiovascularHernán Prat M. Unidad de Factores de Riesgo, Depto. Cardiovascular, Hospital Clínico, Universidad de ChileEntre los factores de riesgo cardiovascular (FRC) más bió la conjunción de hipertensión, hiperglicemia y la gota como conocidos están la hipertensión arterial, el tabaquismo, la un síndrome.(4) Posteriormente, varias otra